Imaging, Pulmonary Function, and Histopathologic Findings of Persistent Fibrosis in a Longitudinal Cohort Three Years after Severe COVID-19 Infection
Preprint
Abstract
Fibrotic-like abnormalities are present in 60% of a single-center, longitudinal, multi-ethnic cohort 3-years after severe COVID-19. They are independently associated with male sex, low BMI, shorter telomere length, increased severity of illness, and mechanical ventilation; Black race and asthma are protective. Participants with fibrotic-like abnormalities are more likely to have reduced diffusion capacity and 6-minute walk distance. Fibrotic-like abnormalities persist but modestly improve over time. Transbronchial biopsies show small airways histopathology, consistent with high prevalence of air trapping in expiration, and infrequent interstitial thickening. This study highlights the need for continued monitoring of patients with persistent fibrosis after severe COVID-19.Keywords
This publication has 10 references indexed in Scilit:
- Post-COVID-19 respiratory sequelae two years after hospitalization: an ambidirectional studyThe Lancet Regional Health - Americas, 2024
- Improved pulmonary function and exercise tolerance despite persistent pulmonary fibrosis over 1 year after severe COVID-19 infectionThorax, 2024
- Short- and Long-Term Chest-CT Findings after Recovery from COVID-19: A Systematic Review and Meta-AnalysisDiagnostics, 2024
- Long-term radiological and pulmonary function abnormalities at 3 years after COVID-19 hospitalisation: a longitudinal cohort studyEuropean Respiratory Journal, 2024
- Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post–COVID-19 StudyAmerican Journal of Respiratory and Critical Care Medicine, 2023
- Relationship between asthma and severe COVID-19: a national cohort studyThorax, 2022
- Quantitative Chest CT Assessment of Small Airways Disease in Post-Acute SARS-CoV-2 InfectionRadiology, 2022
- Shorter leukocyte telomere length is associated with adverse COVID-19 outcomes: A cohort study in UK BiobankEBioMedicine, 2021
- Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere lengthThorax, 2021
- Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 InfectionAnnals of Internal Medicine, 2020